Aprea Therapeutics (NASDAQ:APRE) Releases Earnings Results, Beats Estimates By $0.20 EPS
Aprea Therapeutics (NASDAQ:APRE – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.49) EPS for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.20, Zacks reports. Aprea Therapeutics had a negative return on equity of 57.86% and a negative net margin of 1,029.50%. Aprea Therapeutics Stock Performance Shares of […]
25 Mar 15:08 · The Markets Daily